World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
42215
World Ranking
8500
National Ranking
259

Pascal Hammel publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Pascal Hammel sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 617 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Pascal Hammel D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Pascal Hammel sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2005 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Pascal Hammel is affiliated with the University of Paris-Saclay in France. Their research primarily centers on medicine, with a significant focus on oncology and cancer-related fields. The main fields of study represented in their publications include Medicine and Biochemistry, Genetics and Molecular Biology. Subfields of particular emphasis are Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery, and Epidemiology.

Their work addresses several key topics: pancreatic and hepatic oncology research, cancer genomics and diagnostics, renal cell carcinoma treatment, neuroendocrine tumor research advances, gastric cancer management and outcomes, cholangiocarcinoma and gallbladder cancer studies, and cancer immunotherapy and biomarkers.

Pascal Hammel has contributed research articles to a variety of prominent publication venues. Frequent journals include:

  • Journal of Clinical Oncology
  • Therapeutic Advances in Medical Oncology
  • Annals of Oncology
  • European Journal of Cancer
  • Pancreatology

Recent papers authored by or involving Pascal Hammel cover a range of topics related to cancer treatment and genetics:

  • Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer, 2022, JAMA Oncology
  • Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study, 2020, The Lancet. Gastroenterology & Hepatology
  • Clinical practice guidelines for BRCA1 and BRCA2 genetic testing, 2021, European Journal of Cancer
  • A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma, 2020, Annals of Oncology
  • Activation of lysosomal iron triggers ferroptosis in cancer, 2025, Nature

Collaboration is a notable aspect of Pascal Hammel's research activities. Frequent co-authors include:

  • Jean-Baptiste Bachet
  • Jérôme Cros
  • Anthony Turpin
  • Cindy Neuzillet
  • Rémy Nicolle

Among distinctions received, Pascal Hammel was recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 2005.

Best Publications

  • Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

    Eric Raymond;Laetitia Dahan;Jean Luc Raoul;Yung Jue Bang

  • FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

    Thierry Conroy;Pascal Hammel;Mohamed Hebbar;Meher Ben Abdelghani

  • Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

    John P. Neoptolemos;John P. Neoptolemos;Daniel H. Palmer;Daniel H. Palmer;Paula Ghaneh;Eftychia E. Psarelli

  • Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer

    Talia Golan;Pascal Hammel;Michele Reni;Eric Van Cutsem

  • Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial

    Christophe Louvet;R. Labianca;P. Hammel;G. Lledo

  • Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib the LAP07 randomized clinical trial

    Pascal Hammel;Florence Huguet;Jean-Luc van Laethem;David Goldstein

  • Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study

    B. Chauffert;F. Mornex;Franck Bonnetain;P. Rougier

  • nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

    David Goldstein;Robert Hassan El-Maraghi;Pascal Hammel;Volker Heinemann

  • Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies

    Florence Huguet;Thierry André;Pascal Hammel;Pascal Artru

  • Regression of Liver Fibrosis after Biliary Drainage in Patients with Chronic Pancreatitis and Stenosis of the Common Bile Duct

    Pascal Hammel;Anne Couvelard;Dermot O'Toole;Anne Ratouis

  • Risk of pancreatic adenocarcinoma in chronic pancreatitis

    D Malka;P Hammel;F Maire;P Rufat

  • Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct.

    B Terris;P Ponsot;F Paye;P Hammel

  • Pancreatic involvement in von Hippel–Lindau disease

    Pascal R. Hammel;Valerie Vilgrain;Benoit Terris;Alfred Penfornis

  • Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses

    M Voss;P Hammel;G Molas;L Palazzo

  • Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study

    Julien Edeline;Meher Benabdelghani;Aurélie Bertaut;Jérôme Watelet

  • Risk factors for diabetes mellitus in chronic pancreatitis

    David Malka;Pascal Hammel;Alain Sauvanet;Pierre Rufat

  • Assessment of complications of EUS-guided fine-needle aspiration.

    Dermot O'Toole;Laurent Palazzo;Ramuntçho Arotçarena;Alain Dancour

  • Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial

    David Malka;Pascale Cervera;Stéphanie Foulon;Tanja Trarbach

  • First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

    Harpreet S Wasan;Peter Gibbs;Navesh K Sharma;Julien Taieb

  • The natural history of hereditary pancreatitis : a national series

    V. Rebours;M. C. Boutron-Ruault;M. Schnee;C. Ferec

Frequent Co-Authors

Philippe Ruszniewski
Philippe Ruszniewski Université Paris Cité
Alain Sauvanet
Alain Sauvanet Université Paris Cité
Anne Couvelard
Anne Couvelard Université Paris Cité
Eric Raymond
Eric Raymond St. Joseph Hospital
Valérie Vilgrain
Valérie Vilgrain Université Paris Cité
Thierry André
Thierry André Université Paris Cité
Jacques Belghiti
Jacques Belghiti Beaujon Hospital
David Goldstein
David Goldstein University of New South Wales
Bengt Glimelius
Bengt Glimelius Uppsala University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The medical field offers diverse career options beyond the traditional MD path, and online education makes these pathways more accessible than ever. For those seeking advanced nursing roles, pursuing one of the most affordable online dnp programs can be a practical way to achieve a Doctor of Nursing Practice degree and move into leadership or specialized clinical positions.

Aspiring pharmacists can benefit from online pharm d programs, which allow students to earn a Doctorate in Pharmacy with greater flexibility, making it easier to balance studies with work or family commitments.

For those interested in healthcare administration or data management, earning a health information management degree online equips graduates with the skills to oversee medical data, compliance, and information systems vital to today's health organizations.

Additionally, starting with specialized credentials such as a medical coding certification online offers a quick entry point into the healthcare sector, providing vital support to healthcare providers by ensuring proper billing and insurance processing.

Best Scientists Citing Pascal Hammel

Trending Scientists

Recently Published Articles